• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
1AD 12.5% 2.7¢

ADALTA LIMITED

AdAlta Limited is an Australia-based clinical-stage drug discovery company. The Company... AdAlta Limited is an Australia-based clinical-stage drug discovery company. The Company is engaged in the development of therapeutic products from its i-body platform. The Company has five active development programs ranging from discovery to Phase II clinical trials with applications in the fields of inflammation/fibrosis and immuno-oncology. Its lead product, AD-214, is an antibody therapeutic for the treatment of fibrotic diseases, including lung fibrosis (specifically Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD)), kidney fibrosis, eye fibrosis and some cancers. Chimeric Antigen Receptor (CAR) cell therapies involve modification of a patient’s immune cells (T cells, NK cells, macrophages and other) so that they produce a CAR on the cell surface that enables the patient’s immune system to recognize and kill diseased cells such as cancer. It develops i-body enabled PET (i-PET) imaging agents for use in immuno-oncology. It evaluates several CXCR4 i-bodies.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
1AD 20/05/24 8 1.1K
20/05/24 Last post  Beno77 Comments Created with Sketch.  8  Views Created with Sketch.  1.1K 
1AD 19/05/24 125 25K
19/05/24 Last post  waynesworld Comments Created with Sketch.  125  Views Created with Sketch.  25K 
1AD 17/05/24 3 952
17/05/24 Last post  ForeverNewbie Comments Created with Sketch.  3  Views Created with Sketch.  952 
1AD 13/05/24 4 1.3K
13/05/24 Last post  Duke2 Comments Created with Sketch.  4  Views Created with Sketch.  1.3K 
1AD 13/05/24 8 2.1K
13/05/24 Last post  FXm Comments Created with Sketch.  8  Views Created with Sketch.  2.1K 
1AD
News: 1AD Adalta Says Cell Therapies To Be Preferred Manufacturer Of Cellular Immunotherapies
13/05/24 0 132
13/05/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  132 
1AD 09/05/24 0 186
09/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  186 
1AD 09/05/24 0 151
09/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  151 

See All Discussions arrow Created with Sketch.

Timeline

Investor presentation
20 May 09:40
 
Application for quotation of securities - 1AD
14 May 09:45
 
Cellular immunotherapy manufacturer secured - Cell Therapies
13 May 08:40
 
Cleansing Notice under Section 708A
09 May 08:30
 
Application for quotation of securities - 1AD
09 May 08:24
 
Application for quotation of securities - 1AD
07 May 16:47
 
View More arrow Created with Sketch.
(20min delay)
Last
2.7¢
Change
0.003(12.5%)
Mkt cap ! $12.79M
Open High Low Value Volume
2.5¢ 2.7¢ 2.5¢ $21.51K 834.9K

Buyers (Bids)

No. Vol. Price($)
1 378167 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 157438 1
View Market Depth
Last trade - 10.17am 21/05/2024 (20 minute delay) ?
Last
2.6¢
  Change
0.003 ( 8.33 %)
Open High Low Volume
2.5¢ 2.6¢ 2.5¢ 173986
Last updated 10.17am 21/05/2024 ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.